Time to reconsider thromboembolic risk and anticoagulation in transthyretin cardiac amyloidosis? Porcari A, Merlo M, Sinagra G. Eur J Heart Fail 2022;24:1716-1718.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Porcari A, Merlo M, Sinagra G. Time to reconsider thromboembolic risk and anticoagulation in transthyretin cardiac amyloidosis? Eur J Heart Fail 2022;24:1716-1718.
PMID: 35919942